Latest Breaking News On - Nnova captab ipo listing price prediction - Page 1 : vimarsana.com

The Rs 570-crore public issue of pharmaceutical company had received good response from investors with a subscription of 55.26 times during December 21-26. Qualified institutional buyers (QIBs) bought 116.73 times the portion set aside for them

Jammu and kashmirHong kongSharon bioAjanta pharmaGlenmark pharmaceuticalsIntas pharmaceuticalsEmcure pharmaceuticalsHimachal pradesh basedIndoco remediesZuventus healthcareSharon bio medicineInnova captab ipoInnova captab ipo gmpInnova captab ipo listing dateNnova captab ipo listing priceNnova captab ipo listing price prediction